Leukemia Clinical Trials

Showing 1441-1460 of 10,987 trials

Fluid Balance in Acute Kidney Injury in Critically Ill Patients

NCT07338734

This prospective observational cohort study evaluates if fluid balance in the first 48 hours of ICU admission is linked to acute kidney injury (AKI) in critically ill adults. Patients without AKI at entry will have fluids tracked hourly via charts, weights, and labs to assess AKI risk by KDIGO criteria within 7 days. Findings may guide better fluid management to lower AKI rates.

Fluid BalanceAcute Kidney InjuryCritically Ill Acute Kidney Injury+1 more

Assiut University120 participantsStarted Jan 2026

Not Yet Recruiting

Adoption of Audio Recording in the Outpatient Supportive Care Center

NCT04871477

This study evaluates how patients feel about having an audio recording of their visit to help remember information given to them and share that information with family members and/or caregivers not present during a clinic visit. Information from this study may help evaluate the effectiveness of using technology to help improve patient care by recording consultation recommendations.

Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid Neoplasm+2 more

M.D. Anderson Cancer Center200 participantsStarted Jan 2026

Houston, Texas, United States

RECRUITINGNA

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

NCT04151940

This study investigates the changes in positron emission tomography (PET)/computed tomography (CT) imaging scans during chemoimmunotherapy and radiation therapy treatment in patients with stage IV non-small cell lung cancer. Analyzing changes in PET/CT imaging scans may help doctors assess and predict patterns of cancer response to chemoimmunotherapy and radiation therapy.

Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

University of Washington80 participantsStarted Sep 2019

Seattle, Washington, United States

Fluid Balance in Acute Kidney Injury in Critically Ill Patients

Adoption of Audio Recording in the Outpatient Supportive Care Center

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Related Searches

Chemo Brain Prehab Project

A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer

A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC)

JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer

This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients

Effect of Predictive Model on Double-Balloon Enteroscopy

Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Palliative Care Educator

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients

Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India